Adverse events following immunization of COVID-19 (Covaxin) vaccine at a tertiary care center of India.
Ontology highlight
ABSTRACT: The study aimed to assess the adverse events following COVID-19 vaccine (Covaxin) immunization at a tertiary care institution and also assess the predictors of the adverse events following immunization (AEFI). The prospective observational study was conducted in a tertiary care institute among the Covaxin beneficiaries between June 28 and September 6, 2021. A total of 1826 participants were assessed for any local or systemic adverse events after seven days of vaccination. A telephonic interview was conducted, and the beneficiaries were assessed according to the adverse event grading. A total of 1826 participants were assessed for AEFI, and 544 (29.8%) reported at least one of the AEFI. No severe adverse events were reported, and about 1.6% had moderate AEFI. Pain at the injection site (14.
SUBMITTER: Parida SP
PROVIDER: S-EPMC9088522 | biostudies-literature | 2022 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA